How many insider trades does FilingIQ track for SNSE?

FilingIQ tracks 219 Form 4 insider transactions for SNSE (Sensei Biotherapeutics, Inc.), covering filings from Feb 8, 2021 onwards. 6 of those were filed in the last 90 days.

Are SNSE insiders net buyers or net sellers?

Across the full Form 4 history for SNSE, 133 transactions (61%) were open-market purchases and 22 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does SNSE insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is SNSE in?

Sensei Biotherapeutics, Inc. (SNSE) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $43.96M.

SNSE insider trading

NasdaqCM Healthcare

Sensei Biotherapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

219

Last 90 days

Buys / sells

61% / 10%

Market cap

$43.96M

About Sensei Biotherapeutics, Inc.

Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. It also offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune checkpoint VISTA for the treatment of solid tumors. The company's pipeline includes SNS-102 and SNS-103, an active monoclonal antibody, which are in early development stages for the treatment of solid tumors, as well as SNS-201 is a bispecific antibody targeting CD28. It has a collaboration with The University of Washington to conduct preclinical studies for its solnerstotug program. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.

Company website: www.senseibio.com

SNSE insider activity at a glance

FilingIQ has scored 219 insider transactions for SNSE since Feb 8, 2021. The most recent filing in our index is dated Apr 10, 2026.

Across the full history, 133 open-market purchases and 22 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SNSE insider trades is 53.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live SNSE trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for SNSE?: FilingIQ tracks 219 Form 4 insider transactions for SNSE (Sensei Biotherapeutics, Inc.), covering filings from Feb 8, 2021 onwards. 6 of those were filed in the last 90 days.
Are SNSE insiders net buyers or net sellers?: Across the full Form 4 history for SNSE, 133 transactions (61%) were open-market purchases and 22 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SNSE insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is SNSE in?: Sensei Biotherapeutics, Inc. (SNSE) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $43.96M.

Methodology & sources

Every SNSE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.